Yervoy (ipilimumab) is a prescription drug used to treat melanoma, a type of skin cancer. The drug is manufactured by Bristol-Myers Squibb (BMS) [1]. According to the package insert of Yervoy, the drug is available in a single-use vial containing 50 mg of ipilimumab as a lyophilized powder for reconstitution [2].

As per the Aetna website, the coverage for Yervoy is subject to the terms and conditions of the member's benefit plan. Aetna considers ipilimumab medically necessary for the treatment of melanoma when used in accordance with the Food and Drug Administration (FDA) approved labeling [3].

However, there is no information available on the Drug Patent Watch website regarding any discounts on Yervoy for different dosages.

In conclusion, there is no information available on whether Yervoy discounts are applicable for all dosages. It is recommended to check with the manufacturer or the healthcare provider for any information on discounts. It is also important to check with the insurance provider regarding the coverage of Yervoy for the treatment of melanoma.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/YERVOY
[2] https://packageinserts.bms.com/pi/pi_yervoy.pdf
[3] https://www.aetna.com/cpb/medical/data/800_899/0815.html